Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

Overview of attention for article published in Orphanet Journal of Rare Diseases, September 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 50,345 followers.

RT @RareConnect: Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe? http://t.co/Y8URsY43

RT @RareConnect: Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe? http://t.co/Y8URsY43

Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe? http://t.co/Y8URsY43

Paying for the Orphan Drug System: break or bend? New #HTA ideas from Wills Hughes-Wilson, co-authors #orphaNewsEurope http://t.co/GJikPXrP

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.